House of Commons photoLost her last election, in 2008, with 30% of the vote.
Health Care April 27th, 1994
Mr. Speaker, let me remind the hon. member that my function is to ensure that any medication which receives a notice of compliance is safe and efficacious.
I will only issue a notice of compliance when my department and scientists are absolutely sure it is safe for the people of Canada.
That is the process we follow. It is the process we will continue to follow.
Health Care April 27th, 1994
Mr. Speaker, an application for the BCG therapeutic product used in treating cancer of the bladder was filed by Connaught Laboratories on March 2, 1989. The notice of compliance was issued on April 25, 1990. The approval process thus took 13 1/2 months.
The Biochem file on BCG cancer, a product intended to treat bladder cancer, was received on June 10, 1992. The hon. member must realize that we receive a growing number of submissions of new research drugs and new drugs that qualify for priority evaluation; this increase is mainly due to progress in the biotechnology industry.
These priority applications take precedence over regular ones that are already being processed in order of receipt. Many physicians wishing to obtain the product from Biochem in order
to treat patients in their care can do so through the Emergency Drug Distribution Program.
Canadian Hemophilia Society April 26th, 1994
Mr. Speaker, when there is a judicial inquiry the head of that inquiry has much latitude. As far as I know, he is the one who engaged the committee of experts.
The hon. member speaks of the Canadian Hemophilia Society which has asked for further funding. It is under consideration. However, to date none of the people who wished to appear before the Krever commission has been denied the funding necessary to help them.
Canadian Hemophilia Society April 26th, 1994
Mr. Speaker, Mr. Justice Krever who is in charge of the inquiry spends his money as he sees fit, and in fact, he hired these experts. We remain in touch with the commission, and I must say there have been no problems so far. The people who wish to take part in this inquiry have the right, as well as the funding they need, to appear before the commission.
Biovac April 26th, 1994
Mr. Speaker, I always try to answer the question of the hon. member. When I have the answer, I will give it to her.
Biovac April 26th, 1994
Mr. Speaker, I cannot comment on what happened in the department before my appointment. However, I can tell you that there are many reasons why delays sometimes occur. In this particular case, I could try to get information and answer some time later. You can be assured that we are trying to serve the Canadian people in the best possible way.
Canada Wildlife Act April 25th, 1994
moved for leave to introduce Bill C-24, An Act to amend the Canada Wildlife Act and to make a consequential amendment to another Act.
(Motions deemed adopted, bill read the first time and printed.)
Migratory Birds Convention Act, 1994 April 25th, 1994
moved for leave to introduce Bill C-23, an act to implement a convention for the protection of migratory birds in Canada and the United States.
(Motions deemed adopted, bill read the first time and printed.)
Drinking Water April 25th, 1994
Mr. Speaker, I am concerned with this issue. I have been on top of this issue now for a number of months. I have asked officials in my department to bring forward recommendations so that we can do something as quickly as possible.
Drinking Water April 25th, 1994
Mr. Speaker, yes, I am aware.